Curiously, the strongest anxiolytic effect came from the smallest administered dose of 0.5 mcg/kg body weight, whereas larger doses had smaller effects on anxiety [12]
Chang, C., Tsai, W., Lin, M., Hsu, Y., & Pang, J
GHK-Cu is not a medicine , it is registered as a cosmetic ingredient (INCI: Copper Tripeptide-1) in the EU and USA
2 g in 4 to 6 equally divided doses d
Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain
Because scientific programs often involve the evaluation of multiple compounds within the same category, Nefiracetam may be incorporated into broader analytical frameworks designed to compare material properties and formulation characteristics
